Position in ALKS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$542,917
+$68,768 QoQ
Shares Held
15,354
-9.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AVIVA PLC holds $184,196,374 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
968,672 | $114,506,717 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,300,604 | $39,174,192 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,451 | $20,428,753 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
71,310 | $9,394,379 | |
| 5 | ALKS |
Alkermes plc.
This page
|
15,354 | $542,917 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,695 | $149,416 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $542,917 | 15,354 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $474,149 | 16,946 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $514,350 | 17,145 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $557,723 | 19,494 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $575,373 | 17,425 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $601,486 | 20,914 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $649,200 | 23,194 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $617,345 | 25,616 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $597,380 | 22,068 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||